Kanbay M, Mizrak B, Alper E, Copur S, Ortiz A
Clin Kidney J. 2025; 18(1):sfae359.
PMID: 39781479
PMC: 11704793.
DOI: 10.1093/ckj/sfae359.
Russo E, Gambella M, Raiola A, Beltrametti E, Zanetti V, Chirco G
Sci Rep. 2024; 14(1):26886.
PMID: 39506012
PMC: 11542077.
DOI: 10.1038/s41598-024-77720-z.
Zhang D, Sun D
Front Immunol. 2024; 15:1408718.
PMID: 39234257
PMC: 11372788.
DOI: 10.3389/fimmu.2024.1408718.
Shaikh A
Curr Opin Toxicol. 2024; 31.
PMID: 39086475
PMC: 11290437.
DOI: 10.1016/j.cotox.2022.100362.
Petgrave Y, Selukar S, Epperly R, Naik S, Santos N, Triplett B
Pediatr Nephrol. 2024; 39(8):2495-2503.
PMID: 38507119
PMC: 11199105.
DOI: 10.1007/s00467-024-06331-7.
Acute kidney injury following treatment with CD19-specific CAR T-cell therapy in children, adolescent and young adult patients with B-cell acute lymphoblastic leukemia.
Petgrave Y, Selukar S, Epperly R, Naik S, Santos N, Triplett B
Res Sq. 2023; .
PMID: 37886451
PMC: 10602103.
DOI: 10.21203/rs.3.rs-3396661/v1.
CAR-T Cells and the Kidney: Insights from the WHO Safety Database.
Gerard A, Merino D, Charbinat A, Fournier J, Destere A, Loschi M
BioDrugs. 2023; 37(4):521-530.
PMID: 37166707
PMC: 10287817.
DOI: 10.1007/s40259-023-00599-1.
Safety of CAR-T Cell Therapy in Patients With Renal Failure/Acute Kidney Injury: Focused Review.
Khan I, Khan N, Wolfson N, Djebabria K, Ur Rehman M, Anwer F
Clin Hematol Int. 2023; 5(2-3):122-129.
PMID: 37010812
PMC: 10241763.
DOI: 10.1007/s44228-023-00037-7.
Adverse Renal Effects of Anticancer Immunotherapy: A Review.
Borowka M, Lacki-Zynzeling S, Nicze M, Kozak S, Chudek J
Cancers (Basel). 2022; 14(17).
PMID: 36077623
PMC: 9454552.
DOI: 10.3390/cancers14174086.
Incidence and Risk Factors for Acute Kidney Injury After Chimeric Antigen Receptor T-Cell Therapy.
Farooqui N, Sy-Go J, Miao J, Mehta R, Vaughan L, Bennani N
Mayo Clin Proc. 2022; 97(7):1294-1304.
PMID: 35787856
PMC: 9703303.
DOI: 10.1016/j.mayocp.2022.05.018.
Comprehensive Serum Proteome Profiling of Cytokine Release Syndrome and Immune Effector Cell-Associated Neurotoxicity Syndrome Patients with B-Cell ALL Receiving CAR T19.
Diorio C, Shraim R, Myers R, Behrens E, Canna S, Bassiri H
Clin Cancer Res. 2022; 28(17):3804-3813.
PMID: 35705524
PMC: 9444956.
DOI: 10.1158/1078-0432.CCR-22-0822.
Acute kidney injury caused by haplostorm after allogenic hematopoietic stem cell transplant.
Hanna P, Strohbehn I, Wang Q, Frigault M, Sise M
Bone Marrow Transplant. 2022; 57(9):1442-1444.
PMID: 35661834
DOI: 10.1038/s41409-022-01720-8.
Anticancer Drug-Induced Capillary Leak Syndrome.
Izzedine H, Mathian A, Amoura Z, Ng J, Jhaveri K
Kidney Int Rep. 2022; 7(5):945-953.
PMID: 35570987
PMC: 9091576.
DOI: 10.1016/j.ekir.2022.02.014.
Treatment of acute kidney injury in cancer patients.
Braet P, Re Sarto G, Pirovano M, Sprangers B, Cosmai L
Clin Kidney J. 2022; 15(5):873-884.
PMID: 35498895
PMC: 9050558.
DOI: 10.1093/ckj/sfab292.
Collapsing Focal Segmental Glomerulosclerosis and Acute Kidney Injury Associated With Chimeric Antigen Receptor T-Cell (CAR-T) Therapy: A Case Report.
Acharya R, Horn B, Zeng X, Upadhyay K
Kidney Med. 2021; 3(6):1086-1090.
PMID: 34939018
PMC: 8664733.
DOI: 10.1016/j.xkme.2021.06.011.
